This clearance comes just one month after Corin won FDA clearance for its Unity Knee medial constrained (MC) tibial insert. That implant helps independently stabilize the medial compartment during a standard or robotic-assisted total knee arthroplasty (TKA).

Cirencester, UK-based Corin — which has its U.S. base in Raynham, Massachusetts — designed Icona using comprehensive data from the CorinRegistry. The company says it represents a significant addition to its portfolio of proven implants for THA.

Corin developed the collared, metaphyseal-filling, triple-taper stem for efficient, reproducible canal preparation and ease of insertion during muscle-sparing approaches. Key features include a reduced proximal lateral shoulder, a swept distal tip and a 15-degree angled insertion feature.